Literature DB >> 20045156

Common INSIG2 polymorphisms are associated with age-related changes in body size and high-density lipoprotein cholesterol from young adulthood to middle age.

Myriam Fornage1, George Papanicolaou, Cora E Lewis, Eric Boerwinkle, David S Siscovick.   

Abstract

Insulin-induced gene 2 (INSIG2) plays an important role in the regulation of cholesterol and fatty acids synthesis. A polymorphism, rs7566605, located 10 kilobases upstream of the INSIG2 gene, was identified in a genomewide association study of obesity. We conducted an association study of 12 INSIG2 tag-single nucleotide polymorphisms with longitudinal measures of body size (body mass index and waist circumference) and lipid metabolism (plasma high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides levels). We investigated their interaction with age in 4304 Coronary Artery Risk Development in Young Adults participants (49.5% blacks, 50.5% whites) followed prospectively for 20 years. rs7566605 was not associated with variation in body size or lipid metabolism at any age in either racial group. However, rs1352083 and rs10185316 were associated with age-related decline in high-density lipoprotein cholesterol in whites (P = .0005 and .04, respectively). A similar trend was observed in blacks who consistently maintained a body mass index less than 25 kg/m(2) over the study period. These data support a role of INSIG2 sequence variation in the regulation of cholesterol metabolism. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20045156      PMCID: PMC2888786          DOI: 10.1016/j.metabol.2009.11.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  28 in total

1.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

2.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

3.  Enzymatic methods for quantification of lipoprotein lipids.

Authors:  G R Warnick
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels.

Authors:  Alessandra C Cervino; Guoya Li; Steve Edwards; Jun Zhu; Cathy Laurie; George Tokiwa; Pek Yee Lum; Susanna Wang; Lawrence W Castellani; Lawrence W Castellini; Aldons J Lusis; Sonia Carlson; Alan B Sachs; Eric E Schadt
Journal:  Genomics       Date:  2005-08-29       Impact factor: 5.736

5.  Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins.

Authors:  Daisuke Yabe; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

6.  Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain.

Authors:  Navdar Sever; Tong Yang; Michael S Brown; Joseph L Goldstein; Russell A DeBose-Boyd
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

7.  Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol.

Authors:  Navdar Sever; Bao-Liang Song; Daisuke Yabe; Joseph L Goldstein; Michael S Brown; Russell A DeBose-Boyd
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

8.  Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program.

Authors:  P W Franks; K A Jablonski; L M Delahanty; J B McAteer; S E Kahn; W C Knowler; J C Florez
Journal:  Diabetologia       Date:  2008-10-07       Impact factor: 10.122

9.  CARDIA: study design, recruitment, and some characteristics of the examined subjects.

Authors:  G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

10.  The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts.

Authors:  Jan Bressler; Myriam Fornage; Craig L Hanis; Wen Hong Linda Kao; Cora E Lewis; Ruth McPherson; Robert Dent; Thomas H Mosley; Len A Pennacchio; Eric Boerwinkle
Journal:  BMC Med Genet       Date:  2009-06-12       Impact factor: 2.103

View more
  7 in total

1.  Linkage analysis incorporating gene-age interactions identifies seven novel lipid loci: the Family Blood Pressure Program.

Authors:  Jeannette Simino; Rezart Kume; Aldi T Kraja; Stephen T Turner; Craig L Hanis; Wayne Sheu; Ida Chen; Cashell Jaquish; Richard S Cooper; Aravinda Chakravarti; Thomas Quertermous; Eric Boerwinkle; Steven C Hunt; D C Rao
Journal:  Atherosclerosis       Date:  2014-04-26       Impact factor: 5.162

2.  INSIG2 variants, dietary patterns and metabolic risk in Samoa.

Authors:  A Baylin; R Deka; J Tuitele; S Viali; D E Weeks; S T McGarvey
Journal:  Eur J Clin Nutr       Date:  2012-09-12       Impact factor: 4.016

3.  Controversial association results for INSIG2 on body mass index may be explained by interactions with age and with MC4R.

Authors:  Dörthe Malzahn; Martina Müller-Nurasyid; Iris M Heid; H-Erich Wichmann; Heike Bickeböller
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

4.  The gene-gene interaction of INSIG-SCAP-SREBP pathway on the risk of obesity in Chinese children.

Authors:  Fang-Hong Liu; Jie-Yun Song; Xiao-Rui Shang; Xiang-Rui Meng; Jun Ma; Hai-Jun Wang
Journal:  Biomed Res Int       Date:  2014-06-17       Impact factor: 3.411

5.  Common Genetic Variant of insig2 Gene rs7566605 Polymorphism Is Associated with Severe Obesity in North India

Authors:  Jai Prakash; Balraj Mittal; Srivastava Apurva; Awasthi Shally; Srivastava Pranjal; Srivastava Neena
Journal:  Iran Biomed J       Date:  2017-05-21

6.  Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention.

Authors:  Gloria Pelizzo; Luigi Chiricosta; Emanuela Mazzon; Gian Vincenzo Zuccotti; Maria Antonietta Avanzini; Stefania Croce; Mario Lima; Placido Bramanti; Valeria Calcaterra
Journal:  Pediatr Rep       Date:  2021-01-05

7.  Exome sequence association study of levels and longitudinal change of cardiovascular risk factor phenotypes in European Americans and African Americans from the Atherosclerosis Risk in Communities Study.

Authors:  Elena V Feofanova; Elise Lim; Han Chen; MinJae Lee; Ching-Ti Liu; L Adrienne Cupples; Eric Boerwinkle
Journal:  Genet Epidemiol       Date:  2021-06-24       Impact factor: 2.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.